Texas Instruments Incorporated (TXN):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Texas Instruments Incorporated (TXN) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7095
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Texas Instruments Incorporated (TI) designs and manufactures and sells semiconductors to electronics designers and manufacturers the world over. It offers catalog and application-specific standard semiconductor products through its analog chips and embedded processors divisions. Its analog chips include high volume analog and logic (HVAL), power management (Power), high performance analog (HPA) and silicon valley analog (SVA). TI offers a wide range of digital signal processors (DSPs) and microcontrollers and connectivity products through its embedded processing category. It also offers calculators, legacy wireless products and custom semiconductors. The company along with its subsidiaries operates across Americas, Asia, Europe, the Middle East and Africa. TI is headquartered in Dallas, Texas, the US.

Texas Instruments Incorporated (TXN) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Texas Instruments Incorporated, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Texas Instruments Incorporated, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Texas Instruments Incorporated, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Texas Instruments Incorporated, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Texas Instruments Incorporated, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Texas Instruments Incorporated, Medical Equipment, Deal Details 10
Debt Offering 10
Texas Instruments Raises USD250 Million in Public Offering of 0.875% Notes Due 2017 10
Texas Instruments Raises USD250 Million in Public Offering of 2.75% Notes Due 2021 11
Texas Instruments Raises USD500 Million in Public Offering of 1% Notes Due 2018 12
Texas Instruments Raises USD500 Million in Public Offering of 2.25% Notes Due 2023 13
Texas Instruments Raises USD750 Million in Public Offering of 1.65% Notes Due 2019 14
Texas Instruments Raises USD750 Million in Public Offering of 0.45% Notes Due 2015 15
Acquisition 16
Mindray Medical Completes Acquisition Of Zonare Medical Systems For USD101.7 Million 16
Texas Instruments Incorporated – Key Competitors 18
Texas Instruments Incorporated – Key Employees 19
Texas Instruments Incorporated – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Recent Developments 22
Financial Announcements 22
Jul 24, 2018: Texas Instruments announces Q2 2018 results 22
Corporate Communications 23
Jul 17, 2018: Rich Templeton to reassume President and CEO roles in addition to his current role as Chairman Brian Crutcher resigned as CEO 23
Jun 21, 2018: Martin Craighead to join TI board of directors 24
Appendix 25
Methodology 25
About GlobalData 25
Contact Us 25
Disclaimer 25

List of Tables
Texas Instruments Incorporated, Medical Equipment, Key Facts, 2017 2
Texas Instruments Incorporated, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Texas Instruments Incorporated, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Texas Instruments Incorporated, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Texas Instruments Incorporated, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Texas Instruments Incorporated, Deals By Market, 2012 to YTD 2018 8
Texas Instruments Incorporated, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Texas Instruments Raises USD250 Million in Public Offering of 0.875% Notes Due 2017 10
Texas Instruments Raises USD250 Million in Public Offering of 2.75% Notes Due 2021 11
Texas Instruments Raises USD500 Million in Public Offering of 1% Notes Due 2018 12
Texas Instruments Raises USD500 Million in Public Offering of 2.25% Notes Due 2023 13
Texas Instruments Raises USD750 Million in Public Offering of 1.65% Notes Due 2019 14
Texas Instruments Raises USD750 Million in Public Offering of 0.45% Notes Due 2015 15
Mindray Medical Completes Acquisition Of Zonare Medical Systems For USD101.7 Million 16
Texas Instruments Incorporated, Key Competitors 18
Texas Instruments Incorporated, Key Employees 19
Texas Instruments Incorporated, Subsidiaries 20

List of Figures
Texas Instruments Incorporated, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Texas Instruments Incorporated, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Texas Instruments Incorporated, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Texas Instruments Incorporated, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Texas Instruments Incorporated, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Texas Instruments Incorporated, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Texas Instruments Incorporated, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Texas Instruments Incorporated, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Texas Instruments Incorporated (TXN):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Mitobridge Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Mitobridge Inc (Mitobridge), formerly Mitokyne Inc, a subsidiary of Astellas Pharma Inc is a drug development company that discovers and develops small molecule therapeutics that recovers mitochondrial functions. The company develops therapies for rare diseases and expands into more common d …
  • Stora Enso Oyj (STERV):企業の財務・戦略的SWOT分析
    Stora Enso Oyj (STERV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Ex Scientia Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Ex Scientia Ltd (Ex Scientia) is a biotechnology company that develops compounds with tailored polypharmacology. The company develops a systematic approach to tailoring drugs against polypharmacology profiles for superior clinical efficacy. It also develops molecular design technologies. EX …
  • Bio Techne Corp (TECH):医療機器:M&Aディール及び事業提携情報
    Summary Bio Techne Corp (Bio Techne), formerly Techne, develops, produces, and markets biotechnology products and scientific tools to understand biological processes and drive research. The company’s portfolio encompasses native and recombinant proteins, monoclonal and polyclonal antibodies, immunoa …
  • Seven & i Holdings Co., Ltd.:企業の戦略・SWOT・財務分析
    Seven & i Holdings Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Seven & i Holdings Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Naftogaz of Ukraine:企業の戦略的SWOT分析
    Naftogaz of Ukraine - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • HSBC Trinkaus & Burkhardt Private Banking:企業の戦略・SWOT・財務情報
    HSBC Trinkaus & Burkhardt Private Banking - Strategy, SWOT and Corporate Finance Report Summary HSBC Trinkaus & Burkhardt Private Banking - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • Archroma Management LLC:企業の戦略的SWOT分析
    Archroma Management LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Fubon Bank (Hong Kong) Ltd:企業の戦略的SWOT分析
    Fubon Bank (Hong Kong) Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Apyx Medical Corp (BVX):企業の財務・戦略的SWOT分析
    Summary Apyx Medical Corp (Apyx Medical) formerly known as Bovie Medical Corp is a medical technology company. The company manufactures and develops cosmetic and surgical products. The company also develops J-Plasma, a helium-based plasma surgical product for cutting, coagulation and ablation of sof …
  • Gammon India Ltd (GAMMONIND):企業の財務・戦略的SWOT分析
    Gammon India Ltd (GAMMONIND) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Canon Machinery Inc:企業の戦略的SWOT分析
    Canon Machinery Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • AltaGas Ltd (ALA):企業の財務・戦略的SWOT分析
    AltaGas Ltd (ALA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Burgan Bank Sak:企業の戦略・SWOT・財務分析
    Burgan Bank Sak - Strategy, SWOT and Corporate Finance Report Summary Burgan Bank Sak - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Cannabics Pharmaceuticals Inc (CNBX):製薬・医療:M&Aディール及び事業提携情報
    Summary Cannabics Pharmaceuticals Inc (Cannabics Pharmaceuticals), formerly Thrust Energy Corp, is a drug development company that develops cannabinoid-based therapies for cancer. The company develops High Content Screening (HCS) Platform, an automated cellular imaging and analysis platform designed …
  • Groupe Le Duff S.A.(Foodservice):戦略・SWOT・企業財務分析
    Groupe Le Duff S.A.(Foodservice) - Strategy, SWOT and Corporate Finance Report Summary Groupe Le Duff S.A.(Foodservice) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Edinburgh Bioquarter:製薬・医療:M&Aディール及び事業提携情報
    Summary Edinburgh Bioquarter (BioQuarter) is an academic medical center that offers translational medicine research services. The center develops new treatments for human and animal diseases by creating new drugs, diagnostic tools and medical devices. It conducts research in the field of regenerativ …
  • Sihuan Pharmaceutical Holdings Group Ltd (460):製薬・医療:M&Aディール及び事業提携情報
    Summary Sihuan Pharmaceutical Holdings Group Ltd (Sihuan Pharmaceutical) is a pharmaceutical company that develops, manufactures and markets prescription drugs. The company offers products in the therapeutic areas of cardio-cerebral vascular system, central nervous system, metabolism, oncology and a …
  • Mitsubishi Corporation (8058):電力:M&Aディール及び事業提携情報
    Summary Mitsubishi Corporation (Mitsubishi) is an integrated company that develops and operates businesses across industry including industrial finance, energy, metals, machinery, chemicals, living essentials, and environmental business. The company manufactures and markets a wide range of products, …
  • JRI Orthopaedics Ltd:企業の製品パイプライン分析2018
    Summary JRI Orthopaedics Ltd (JRI) a subsidiary of Orthopaedic Research UK (ORUK), is a manufacturer of orthopaedic implants and surgical instruments. The company develops products for joint replacement, repair and reconstruction. It offers products for shoulder and knee arthoplasty, besides customi …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆